PVI
GH icon

Pura Vida Investments’s Guardant Health GH Stock Holding History

Pura Vida Investments’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100,000
Closed -$2.89M – 50
2024
Q2 		$2.89M Sell
100,000
-223,300
-69% -$5.2M 1.83% 20
2024
Q1 		$6.67M Buy
323,300
+223,300
+223% +$4.79M 1.12% 18
2023
Q4 		$2.71M Buy
+100,000
New +$2.62M 0.41% 32
2023
Q1 		– Sell
-408,900
Closed -$11.1M – 118
2022
Q4 		$11.1M Sell
408,900
-161,100
-28% -$7.37M 0.57% 44
2022
Q3 		$30.7M Buy
570,000
+105,000
+23% +$5.39M 1.78% 15
2022
Q2 		$18.8M Buy
465,000
+190,000
+69% +$9.41M 1.09% 22
2022
Q1 		$18.2M Buy
275,000
+255,000
+1,275% +$17.5M 0.59% 39
2021
Q4 		$2M Buy
+20,000
New +$2.07M 0.07% 149
2021
Q1 		– Sell
-20,000
Closed -$2.58M – 228
2020
Q4 		$2.58M Buy
+20,000
New +$2.3M 0.09% 135
2020
Q1 		– Sell
-66,000
Closed -$5.16M – 106
2019
Q4 		$5.16M Buy
+66,000
New +$4.76M 0.45% 54

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Pura Vida Investments's GH Position: Q2 2024 in Review

Pura Vida Investments sold out of Guardant Health (GH) in Q2 2024, closing a stake of 100,000 shares — an estimated $2.33M sold.

Pura Vida Investments first reported a position in GH in Q4 2018 and held it in 20 quarters. The position peaked at $21.6M in Q3 2022. 282 funds tracked by Wall St. Rank hold GH as of Q2 2024.

  • Pura Vida Investments reported no remaining Guardant Health position as of Q2 2024 after selling out during the quarter.
  • Pura Vida Investments sold 100,000 Guardant Health shares in Q2 2024, an estimated $2.33M.
  • Pura Vida Investments first reported a position in Guardant Health in Q4 2018 and held it in 20 quarters.
  • Pura Vida Investments's Guardant Health position peaked at $21.6M in Q3 2022.
  • 282 funds tracked by Wall St. Rank held Guardant Health as of Q2 2024.

Based on Pura Vida Investments's 13F filing for Q2 2024, filed 14 Aug 2024.